D-dimer testing is useful for excluding venous thromboembolism (VTE), where a low D-dimer level helps exclude deep vein thrombosis (DVT) and pulmonary embolism (PE).[1][1] However, elevated levels are ...

Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...

Molecular analysis of RAS genes mutations in patients with cervical adenocarcinoma. The acceleration of adoption of tumor profiling into routine clinical practice: An insight from review of the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than one-quarter of patients with COVID-19 had ...

A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), the peer-reviewed ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

Use of clinical decision rules in conjunction with D-dimer thresholds adjusted higher based on either age or pretest probability is acceptably safe for ruling out acute pulmonary embolism (PE) without ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?